2-73986473-C-T
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_001287491.2(TET3):c.70C>T(p.Gln24*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Genomes: not found (cov: 32)
Consequence
TET3
NM_001287491.2 stop_gained
NM_001287491.2 stop_gained
Scores
4
Clinical Significance
Conservation
PhyloP100: 1.47
Genes affected
TET3 (HGNC:28313): (tet methylcytosine dioxygenase 3) Enables methyl-CpG binding activity and zinc ion binding activity. Involved in histone H3-K4 trimethylation; positive regulation of transcription by RNA polymerase II; and protein O-linked glycosylation. Predicted to be located in cytoplasm and male pronucleus. Predicted to be active in nucleus. Biomarker of esophagus squamous cell carcinoma. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. There are 8 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 2-73986473-C-T is Pathogenic according to our data. Variant chr2-73986473-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 3376267.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TET3 | NM_001287491.2 | c.70C>T | p.Gln24* | stop_gained | 2/12 | ENST00000409262.8 | NP_001274420.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TET3 | ENST00000409262.8 | c.70C>T | p.Gln24* | stop_gained | 2/12 | 1 | NM_001287491.2 | ENSP00000386869.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 30
GnomAD4 exome
Cov.:
30
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Beck-Fahrner syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Pittsburgh Clinical Genomics Laboratory, University of Pittsburgh Medical Center | Aug 22, 2023 | This sequence variant is a single nucleotide substitution (C>T) at coding position 70 of the TET3 gene that generates a premature stop codon at residue 24 of the TET3 protein. This variant is predicted to generate a non-functiol allele through either the expression of a truncated protein or a loss of TET3 expression due to nonsense mediated decay. This is a novel variant that has not been previously reported in databases of clinically annotated variants (ClinVar) or observed in the literature in individuals with TET3-related disease. This variant is absent from control population datasets (gnomAD database 0 of ~31,000 alleles). Because loss of function alleles in TET3 are known to be pathogenic (PMID 31928709), we consider this variant to be likely pathogenic. ACMG Criteria: PM2, PVS1 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Benign
FATHMM_MKL
Benign
D
Vest4
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.